U.S. Physical Therapy (USPH) Q2 2026 Earnings Call Summary

1Key Financial Results and Metrics

Total Revenue: $214 million, up 8.5% year-over-year.

Physical Therapy Revenue: $182 million, an 8.4% increase, with a 3.5% rise in mature clinics.

Visits: 1.662 million, a 6.6% increase; average daily visits per clinic reached 33.5.

Net Revenue per Visit: $107.59, up $2.26 from the previous year.

Adjusted EBITDA: $27 million, slightly up from $26.9 million in Q2 2025.

Net Income: $9.9 million, down from $12.4 million in Q2 2025; EPS decreased to $0.25 from $0.58.

Adjusted Operating Results: $11.3 million, down from $12.4 million in the prior year.

Cash and Cash Equivalents: $25 million, down from $36 million at the end of 2025.

Interest Expense: Increased to $3.2 million from $2.4 million year-over-year.

2Strategic Updates and Business Highlights

Hospital Affiliations: Successful transition of 60 metro clinics to NYU Langone, with significant hiring of 50 clinicians to support growth.

Volume Growth: Year-over-year growth of over 100,000 visits at Metro before hospital support.

Acquisitions: Recently announced acquisition of a 12-clinic practice for $16.4 million, expected to generate $12 million in annual revenue.

Digital Initiatives: Plans to enhance digital and hybrid service offerings for 2027.

Injury Prevention (IIP) Revenue: Grew by 9.1% year-over-year, with stable margins.

3Forward Guidance and Outlook

2026 Adjusted EBITDA Guidance: Reaffirmed at $102 million to $106 million.

Hospital Affiliations Impact: Anticipated revenue lift from hospital partnerships expected to increase in Q4 2026 and into 2027.

Medicare Rate Increase: Projected 1.75% increase for 2027, expected to provide an additional $2.5 million in revenue.

4Challenges and Points of Concern

Self-Insured Healthcare Costs: Increased by approximately $3.2 million year-over-year due to significant claims, impacting margins.

Adjusted Gross Profit Margin: Declined to 19.9% from 21.4% in Q2 2025, primarily due to higher employee medical costs.

Commercial Revenue Growth: Slightly lower than expected at 1.2% increase, which may indicate competitive pressures or contract timing issues.

Temporary Loss of Contracts: Notable loss of a contract with a major automobile manufacturer, which impacted IIP growth.

5Notable Q&A Insights

Cost Management: The hiring of clinicians in advance of expected volume increases was a strategic move, with costs expected to be reimbursed under hospital agreements.

Volume Expectations: Hospital-affiliated clinics are averaging about 45 visits per day, with expectations for growth as partnerships mature.

M&A Activity: Continued focus on acquisitions, with discussions ongoing for additional partnerships in both physical therapy and injury prevention sectors.

Payer Mix Stability: Self-pay remains low at around 3.5% to 4%, with no significant swings in the payer mix noted.

Future Partnerships: Confidence in expanding hospital partnerships, with expectations for more announcements in 2027. This summary encapsulates the key financial metrics, strategic initiatives, forward guidance, challenges, and insights from the Q&A session, providing a balanced view of USPH's current performance and outlook.